You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 204 No. 2, April 8, 1968 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Observations of Possible Barbiturate Interference With Anticoagulation

Murdo G. MacDonald, MD; Donald S. Robinson, MD

JAMA. 1968;204(2):97-100.


Abstract

Sixty-seven bleeding reactions occurred during anticoagulant therapy. In 14 patients, enzyme induction appeared to be a factor, and two of these patients died. The records were reviewed of 52 patients who were admitted for myocardial infarction and treated with anticoagulants. Forty patients received barbiturates and showed more erratic control of anticoagulant effect (and a shorter prothrombin time in spite of a larger dose of warfarin sodium) than the group not receiving barbiturates.

Barbiturate interference with anticoagulant activity of coumarin drugs by enzyme induction is well documented in animals. Circumstantial evidence suggests that it also occurs in man. Awareness of this type of drug interaction and close attention to proper anticoagulant dose based on frequent prothrombin determinations can prevent some of the problems that occur during anticoagulant treatment.



Author Affiliations

From the University of Vermont College of Medicine and the Mary Fletcher Hospital, Burlington. Dr. Robinson is now with the Experimental Therapeutics Branch, National Heart Institute, Bethesda, Md.


Footnotes

Reprint requests to University of Vermont College of Medicine, Burlington, Vt 05401 (Dr. MacDonald).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Presenile Cataracts in Phenytoin-Treated Epileptic Patients
Bar et al.
Arch Ophthalmol 1983;101:422-425.
ABSTRACT  

Pharmacokinetic Drug Interactions: Sedative, Hypnotic, and Antianxiety Agents
Kosman
JAMA 1974;229:1485-1488.
ABSTRACT  

The Clinical Pharmacology of Imipramine: Implications for Therapeutics
Glassman and Perel
Arch Gen Psychiatry 1973;28:649-653.
ABSTRACT  

The Clinical Choice of Sedative-Hypnotics
GREENBLATT and SHADER
ANN INTERN MED 1972;77:91-100.
ABSTRACT  

Prothrombin Levels Maintained With Meprobamate and Warfarin: A Controlled Study
Gould et al.
JAMA 1972;220:1460-1462.
ABSTRACT  

Studies of the Epidemiology of Anticoagulant-Drug Interactions
Kleinman and Griner
Arch Intern Med 1970;126:522-523.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.